DucommunDCO
DCO logo
Fair Value
US$212
Share price22 Aug
US$185.3612.6% undervalued intrinsic discount
Loading
1Y101.02%
7D-7.39%

Defense Modernization And Aerospace Recovery Will Reshape Markets

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
16 Sep 24
Updated
22 Aug 26
Views
207
Not Invested

Last Update 22 Aug 26

Fair value Increased 11%

DCO: Missile Upside And Aero Recovery Will Offset Valuation And Budget Headwinds

The analyst fair value estimate for Ducommun has been raised from $190.80 to $212.00 as analysts factor in higher Street price targets from Citi and Truist, supported by reported missiles growth and updated aerospace and defense models.

Analyst Commentary

Recent Street commentary on Ducommun gives you a mix of optimism around missiles exposure and commercial aerospace, with some caution on how much of that story is already reflected in the share price. Several firms have lifted their price targets through 2024, while one has stepped back on rating despite a higher target, which gives a useful balance of views on valuation and execution risk.

Bullish Takeaways

  • Bullish analysts have raised Ducommun price targets multiple times through 2024, which signals increased confidence in the company’s ability to execute on its current aerospace and defense programs at the prices they model.
  • Missiles exposure is a key support for the bullish case, with reported 68% year over year growth and 29% growth over the last 12 months in that business providing a tangible data point for revenue momentum in that segment.
  • One research update highlights commercial aerospace performance that was better than anticipated, with production deliveries ramping alongside higher OEM production rates, which supports the view that Ducommun is participating in that recovery.
  • Bullish analysts who updated their aerospace and defense coverage ahead of Q2 reporting saw more share price opportunity in defense stocks generally. They cited what they describe as compressed multiples for the group, which frames Ducommun as part of a wider re‑rating argument.

Bearish Takeaways

  • Bearish analysts, while lifting their price target, downgraded Ducommun to a more neutral rating as they see current consensus estimates already reflecting the upside from missiles and munitions activity, which limits perceived near term upside.
  • There is concern about potential budget pressure on Ducommun legacy defense portfolio, which could weigh on growth if funding priorities shift away from those programs even as missiles related demand remains supportive.
  • Some commentary suggests that near term upside is priced in at the current valuation, which implies less room for positive surprise without stronger execution or new contract wins than are currently modeled.
  • One bullish note on Q1 acknowledged that destocking is still expected to be an issue for coming quarters in commercial aerospace, which could create some volatility in revenue timing even if long term demand remains intact.

What’s in the News for Ducommun

  • Ducommun reported Q2 2026 revenue of US$224.5 million, which management and analysts described as 11% to 12% year over year growth, with adjusted EPS of US$1.18 that was 20.2% above consensus estimates. Source: recent earnings reports and analyst commentary.
  • Operating margin for Q2 2026 was 12.6%, compared with 8.5% in the prior year period, reflecting higher profitability on the reported revenue base. Source: Ducommun Q2 2026 results.
  • The Electronic Systems segment generated US$131.4 million in Q2 2026 revenue, which was described as 19.8% growth supported by demand in both defense and commercial aerospace. Source: Ducommun Q2 2026 segment disclosure.
  • RBC Capital Markets commented that, despite the strong Q2 2026 performance, the firm views much of the near term upside as already reflected in Ducommun stock and suggested that investors moderate expectations for immediate share price gains. Source: RBC Capital Markets research.
  • Ducommun has been reclassified across several Russell indices, including additions to the Russell 2000 Growth Benchmark, Russell 2500 Growth Benchmark, Russell 2000 Growth Defensive Index, Russell 2000 Dynamic Index, Russell Small Cap Comp Growth Benchmark and Russell 3000 Growth Benchmark, with simultaneous removals from indices such as the Russell Microcap Index, Russell Microcap Value Benchmark, Russell 3000E Index and Russell 3000E Value Benchmark. Source: index provider corporate actions.

Valuation Changes for Ducommun

  • Fair Value has risen from $190.80 to $212.00, which marks a moderate uplift in the analyst estimate for Ducommun.
  • Discount Rate has edged up slightly from 8.19% to 8.19%, implying a very small change in the assumed risk profile.
  • Revenue Growth has moved from 7.87% to 8.36%, reflecting a higher modeled top line growth rate for Ducommun.
  • Net Profit Margin has shifted from 13.69% to 13.27%, which is a small reduction in the projected profitability level.
  • Future P/E has increased from 24.38x to 27.57x, indicating a higher valuation multiple being applied to Ducommun earnings in the updated model.
2 viewsusers have viewed this narrative update

Key Takeaways

  • Expansion in defense and commercial aerospace, driven by rising demand and modernization, positions Ducommun for sustained top-line growth and increased order activity.
  • Strategic focus on higher-margin products, automation, and domestic sourcing is improving margins, cash flow stability, and overall earnings quality.
  • Heavy dependence on volatile aerospace and defense markets, operational execution challenges, and uncertainty in acquisitions threaten Ducommun's revenue growth, margin stability, and diversification efforts.

Catalysts

About Ducommun
    Provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States.
What are the underlying business or industry changes driving this perspective?
  • Elevated global defense spending and the replenishment of missile and radar inventories-highlighted by strong double-digit growth in both segments and a 30% increase in missile backlog-positions Ducommun to sustain and expand revenue as defense modernization accelerates over the next several years, with increasing program content and order activity.
  • Strengthening demand for commercial aircraft, particularly with increasing Boeing 737 and 787 build rates and projected end to destocking in 2025/2026, underpins a likely recovery and longer-term rebound in top-line growth for Ducommun's commercial aerospace business.
  • Ongoing mix shift toward higher-margin engineered products and aftermarket (maintained at 23% of revenues, moving toward 25%+), together with value-driven pricing and restructuring actions, is increasing gross margins (recorded at 26.6% in Q2), which supports sustained improvements in net margins and earnings.
  • Facility consolidations, automation, and digital initiatives expected to generate $11-13 million in annual savings (with full benefits ramping in late 2025–2026), set the stage for further operating margin expansion and better cash flow conversion (targeting 100% in the coming years).
  • Minimal exposure to tariff impacts, and high percentage of domestic production and sourcing, should allow Ducommun to capitalize on the industry-wide shift toward supply chain localization, potentially capturing increased market share and stabilizing contract flows, thereby reducing earnings volatility and supporting stable free cash flow.
Ducommun Earnings and Revenue Growth

Ducommun Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Ducommun's revenue will grow by 8.4% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -2.5% today to 13.3% in 3 years time.
  • Analysts expect earnings to reach $146.1 million (and earnings per share of $8.98) by about August 2029, up from -$21.2 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 28.6x on those 2029 earnings, up from -136.5x today. This future PE is lower than the current PE for the US Aerospace & Defense industry at 39.9x.
  • Analysts expect the number of shares outstanding to grow by 1.03% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.19%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Ducommun continues to face significant cyclical risk connected to commercial aerospace customers like Boeing and Spirit AeroSystems; persistent destocking and uncertain ramp-up timelines introduce volatility in aerospace revenue, which could negatively impact top-line growth in low-demand cycles.
  • There is a growing concentration of revenue from the defense sector, especially missile and radar programs, exposing the company to shifts in U.S. government defense budgets and platform priorities-potentially impacting both revenue and margin stability if defense spending slows or focus shifts away from Ducommun's key franchises.
  • Execution risks associated with facility consolidation, product line recertification, and transitioning work to new or lower-cost locations (such as the ramp-up at Coxsackie and Guaymas) may lead to unforeseen production delays, temporary operating inefficiencies, or customer disruptions, adversely affecting near
  • and mid-term margins and earnings.
  • Ducommun's ability to scale up its higher-margin engineered product and aftermarket portfolio partly hinges on successful and timely acquisitions; intensifying competition for quality assets or delayed/integrated acquisitions could slow margin expansion and inhibit revenue diversification, limiting the pace of long-term earnings growth.
  • Sustained pressure from unfavorable sales mix (as seen in lower Structural Systems margins) and ongoing restructuring costs, combined with reliance on favorable product mix for margin gains, may challenge the company's ability to consistently expand net margins and achieve targeted profitability if market or execution tailwinds weaken.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $212.0 for Ducommun based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $1.1 billion, earnings will come to $146.1 million, and it would be trading on a PE ratio of 28.6x, assuming you use a discount rate of 8.2%.
  • Given the current share price of $191.65, the analyst price target of $212.0 is 9.6% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Ducommun?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Comments

0 comments

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$212
vs US$185.3612.6% undervalued intrinsic discount
PastFuture-53m1b2015201820212024202620272029Revenue US$1.1bEarnings US$146.1m
8.4%
Revenue growth
13.3%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Ducommun

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Excellent balance sheet and fair value.

Market capUS$2.7b
PB4.1x
Estimated Growth8.5%
Dividend YieldN/A
Full analysis

CEO & management

Stephen Oswald
CEO
8.9yrs
CEO Tenure

Provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States.